Xiu-Bao Chang

3.1k total citations · 1 hit paper
33 papers, 2.5k citations indexed

About

Xiu-Bao Chang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiu-Bao Chang has authored 33 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiu-Bao Chang's work include Drug Transport and Resistance Mechanisms (15 papers), Cystic Fibrosis Research Advances (13 papers) and Pediatric Hepatobiliary Diseases and Treatments (7 papers). Xiu-Bao Chang is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Cystic Fibrosis Research Advances (13 papers) and Pediatric Hepatobiliary Diseases and Treatments (7 papers). Xiu-Bao Chang collaborates with scholars based in United States, Canada and France. Xiu-Bao Chang's co-authors include John R. Riordan, Yue-xian Hou, Liying Cui, Andrei A. Aleksandrov, Martina Gentzsch, Luba A. Aleksandrov, Chang-Xin Shi, P. Leif Bergsagel, Rafaël Fonseca and A. Keith Stewart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Xiu-Bao Chang

33 papers receiving 2.5k citations

Hit Papers

Cereblon expression is required for the antimyeloma activ... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiu-Bao Chang United States 23 1.5k 916 730 558 207 33 2.5k
Stephen O. Brennan New Zealand 26 814 0.5× 905 1.0× 330 0.5× 657 1.2× 301 1.5× 105 2.5k
Alain Kitzis France 23 964 0.6× 306 0.3× 246 0.3× 337 0.6× 159 0.8× 83 1.9k
Sophie Jallat France 11 918 0.6× 810 0.9× 183 0.3× 495 0.9× 80 0.4× 16 2.1k
Izumi Yanatori Japan 21 821 0.5× 412 0.4× 163 0.2× 497 0.9× 256 1.2× 32 1.8k
Frédéric Mazurier France 29 1.6k 1.1× 194 0.2× 498 0.7× 758 1.4× 268 1.3× 67 2.8k
Mary Migliorini United States 24 958 0.6× 302 0.3× 241 0.3× 289 0.5× 405 2.0× 42 2.2k
William F. Glass United States 23 768 0.5× 322 0.4× 386 0.5× 121 0.2× 193 0.9× 63 2.0k
Douglas C. Marchion United States 23 1.8k 1.2× 155 0.2× 609 0.8× 137 0.2× 104 0.5× 66 2.3k
Bibek Gooptu United Kingdom 25 1.0k 0.7× 228 0.2× 445 0.6× 354 0.6× 579 2.8× 45 2.1k
Liying Cui United States 22 1.1k 0.7× 1.3k 1.4× 389 0.5× 18 0.0× 270 1.3× 29 2.1k

Countries citing papers authored by Xiu-Bao Chang

Since Specialization
Citations

This map shows the geographic impact of Xiu-Bao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu-Bao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu-Bao Chang more than expected).

Fields of papers citing papers by Xiu-Bao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiu-Bao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu-Bao Chang. The network helps show where Xiu-Bao Chang may publish in the future.

Co-authorship network of co-authors of Xiu-Bao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiu-Bao Chang. A scholar is included among the top collaborators of Xiu-Bao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiu-Bao Chang. Xiu-Bao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qinqin, Yue-xian Hou, Paul R. Langlais, et al.. (2016). Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival. BMC Cancer. 16(1). 297–297. 35 indexed citations
2.
Chang, Xiu-Bao, et al.. (2011). What is the functional role of the thalidomide binding protein cereblon?. PubMed. 2(3). 287–94. 46 indexed citations
3.
Chang, Xiu-Bao. (2009). Molecular Mechanism of ATP-Dependent Solute Transport by Multidrug Resistance-Associated Protein 1. Methods in molecular biology. 596. 223–249. 23 indexed citations
4.
Chang, Xiu-Bao, April Mengos, Yue-xian Hou, et al.. (2008). Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator. Journal of Cell Science. 121(17). 2814–2823. 65 indexed citations
5.
Chang, Xiu-Bao. (2007). A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1. Cancer and Metastasis Reviews. 26(1). 15–37. 55 indexed citations
6.
Trompier, Doriane, et al.. (2007). (R)- and (S)-Verapamil Differentially Modulate the Multidrug-resistant Protein MRP1. Journal of Biological Chemistry. 282(43). 31542–31548. 58 indexed citations
8.
Hegedűs, Tamás, Andrei A. Aleksandrov, Liying Cui, et al.. (2006). F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758(5). 565–572. 48 indexed citations
9.
Cui, Liying, Luba A. Aleksandrov, Xiu-Bao Chang, et al.. (2006). Domain Interdependence in the Biosynthetic Assembly of CFTR. Journal of Molecular Biology. 365(4). 981–994. 182 indexed citations
10.
Yang, Runying, Ali McBride, Yue-xian Hou, Aaron D. Goldberg, & Xiu-Bao Chang. (2005). Nucleotide dissociation from NBD1 promotes solute transport by MRP1. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1668(2). 248–261. 19 indexed citations
11.
Gentzsch, Martina, Xiu-Bao Chang, Liying Cui, et al.. (2004). Endocytic Trafficking Routes of Wild Type and ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator. Molecular Biology of the Cell. 15(6). 2684–2696. 177 indexed citations
12.
Chang, Xiu-Bao, et al.. (2004). Mutation of the Aromatic Amino Acid Interacting with Adenine Moiety of ATP to a Polar Residue Alters the Properties of Multidrug Resistance Protein 1. Journal of Biological Chemistry. 279(47). 48505–48512. 22 indexed citations
14.
Gentzsch, Martina, et al.. (2003). The PDZ-binding Chloride Channel ClC-3B Localizes to the Golgi and Associates with Cystic Fibrosis Transmembrane Conductance Regulator-interacting PDZ Proteins. Journal of Biological Chemistry. 278(8). 6440–6449. 114 indexed citations
15.
Hou, Yue-xian, Liying Cui, John R. Riordan, & Xiu-Bao Chang. (2002). ATP Binding to the First Nucleotide-binding Domain of Multidrug Resistance Protein MRP1 Increases Binding and Hydrolysis of ATP and Trapping of ADP at the Second Domain. Journal of Biological Chemistry. 277(7). 5110–5119. 52 indexed citations
17.
Chang, Xiu-Bao, Liying Cui, Yue-xian Hou, et al.. (1999). Removal of Multiple Arginine-Framed Trafficking Signals Overcomes Misprocessing of ΔF508 CFTR Present in Most Patients with Cystic Fibrosis. Molecular Cell. 4(1). 137–142. 127 indexed citations
18.
Chang, Xiu-Bao, Yue-xian Hou, & John R. Riordan. (1998). Stimulation of ATPase Activity of Purified Multidrug Resistance-associated Protein by Nucleoside Diphosphates. Journal of Biological Chemistry. 273(37). 23844–23848. 33 indexed citations
19.
Chang, Xiu-Bao, Yue-xian Hou, & John R. Riordan. (1997). ATPase Activity of Purified Multidrug Resistance-associated Protein. Journal of Biological Chemistry. 272(49). 30962–30968. 126 indexed citations
20.
Zheng, Hui, Xiu-Bao Chang, & John H. Wilson. (1989). Primary cells and established cell lines join DNA ends with the same efficiency relative to homologous recombination. Plasmid. 22(2). 99–105. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026